Accelerating AI Governance Maturity From Principles into Practice | Spotlight: Madrigal Pharmaceuticals

This is a webinar landing page, not a standalone case study, confirming the input description. It promotes an on-demand Credo AI session on operationalizing AI governance, with a spotlight segment featuring Madrigal Pharmaceuticals, a clinical-stage biopharmaceutical company, discussing "their vision for AI-native pharma in 2030, ranging from third party AI vetting to autonomous decision-making." It is presented by Parth Patel (Executive Director of AI and Data Science at Madrigal) and Jeff Sizemore (Head of Advisory Services at Credo AI), addressing how enterprises can move beyond theoretical principles to scalable governance for LLMs, multi-agent systems, and generative AI in regulated environments. No case-study outcomes or metrics are presented; the page also promotes other related on-demand sessions.

Credo AI is an AI governance, risk and compliance platform used to inventory AI systems, enforce policy, and generate audit-ready evidence across the AI lifecycle.

This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.